A novel irreversible antagonist of the A1-adenosine receptor

Molecular Pharmacology

Volumn 50, Issue 1, 1996, Pages 196-205

  Srinivas, Miduturu ^a   Shryock, John C ^b   Scammells, Peter J ^c   Ruble, Jackie ^b   Baker, Stephen P ^a   Belardinelli, Luiz ^a,b  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c DEAKIN UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 8 CYCLOPENTYL 3 [3 [[4 (FLUOROSULFONYL)BENZOYL]OXY]PROPYL] 1 PROPYLXANTHINE; ADENOSINE A1 RECEPTOR; ADENOSINE A1 RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN MEMBRANE; CONTROLLED STUDY; GUINEA PIG; HEART CONDUCTION; HEART MUSCLE FIBER MEMBRANE; MEMBRANE BINDING; NONHUMAN; POTASSIUM CURRENT; PRIORITY JOURNAL;

ADENOSINE; ANIMALS; CARBACHOL; DOSE-RESPONSE RELATIONSHIP, DRUG; GTP-BINDING PROTEINS; GUANOSINE 5'-O-(3-THIOTRIPHOSPHATE); GUANYLYL IMIDODIPHOSPHATE; GUINEA PIGS; HEART; HEART ATRIA; ISOPROTERENOL; KINETICS; MEMBRANE POTENTIALS; MYOCARDIUM; PATCH-CLAMP TECHNIQUES; POTASSIUM CHANNELS; RADIOLIGAND ASSAY; RECEPTORS, PURINERGIC P1; THEOPHYLLINE; XANTHINES;

EID: 0030008733     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Belardinelli, L., J. Linden, and R. M. Berne. The cardiac effects of adenosine. Prog. Cardiovasc. Dis. 32:73-97 (1987).
2. Gerlach, E., and B, F. Becker, eds. Topics and Perspectives in Adenosine Research. Springer-Verlag, Berlin (1987).
3. Belardinelli, L., and A. Pelleg, eds. Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology. Kluwer Academic Publishers, Norwell, MA (1995).
4. 1 adenosine receptor: identification of the binding subunit by photoaffinity crosslinking. J. Biol. Chem. 260:10806-10811 (1985).
5. 1 adenosine receptors: persistent activation reveals spare receptors. Mol. Pharmacol. 30:403-409 (1986).
6. 1 adenosine receptor: identification of binding subunit. Mol. Pharmacol. 34:724-728 (1988).
7. 1-adenosine receptors. J. Med. Chem. 32:1043-1051 (1989).
8. 1-adenosine receptors in guinea pig atrioventricular node. Am. J. Physiol. 262:H1070-H1078 (1992).
9. 1-adenosine receptors. J. Med. Chem. 37:2704-2712 (1994).
10. Isenberg, G., and U. Klokner. Calcium tolerant myocytes prepared by preincubation in a "KB medium." Pfluegers Arch. 395:6-18 (1982).
11. Hamill, O. P., A. Marty, E. Neher, B. Sakmann, and F. J. Sigworth. Improved patch clamp techniques for high resolution current recordings from cells and cell-free membrane patches. Pfluegers Arch. 391:85-100 (1981).
12. Jenkins, J., and L. Belardinelli. Atrioventricular nodal accommodation in isolated guinea pig hearts: physiological significance and role of adenosine. Circ. Res. 63:97-116 (1988).
13. Clemo, H. F., and L. Belardinelli. Effect of adenosine on atrioventricular conduction. I. Site and characterization of adenosine action in the guinea pig atrioventricular node. Circ. Res. 59:427-436 (1986).
14. + channels by adenosine in isolated atrial myocytes: involvement of GTP-binding proteins. Pfluegers Arch. 407:264-274 (1986).
15. Dickinson, K. E., S. L. Heald, P. W. Jeffs, R. J. Lefkowitz, and M. G. Caron. Covalent labeling of the β-adrenergic ligand binding site with para-(bromoacteamidyl)benzylcarazolol: a highly potent β-adrenergic affinity label. Mol. Pharmacol. 27:499-506 (1985).
16. 3H] phenoxybenzamine. J. Biol. Chem. 259:7864-7869 (1984).
17. 1MF-2 cells. J. Pharmacol Exp. Ther. 275:1167-1176 (1995).
18. Green, A., and J. L. Johnson. Evidence for impaired coupling of receptors to Gj protein in adipocytes from streptozocin-induced diabetic rats. Diabetes 40:88-94 (1991).
19. 6-((R)-phenylisopropyl)adenosine-induced cognitive disturbance. J. Med. Chem. 36:2508-2518 (1993).
20. Daly, J. W., and K. A. Jacobson. Adenosine receptors: selective agonists and antagonists, in Adenosine and Adenine Nucleotides: From Molecular Biology to Integrative Physiology. (L. Belardinelli and A. Pelleg, eds.). Kluwer Academic Publishers, Norwell, MA (1995).
21. Kollias-Baker, C., J. Xu, A. Pelleg, and L. Belardinelli. Novel approach for enhancing atrioventricular nodal conduction delay mediated by endogenous adenosine. Circ. Res. 75:972-980 (1994).
22. Kenakin, T. P. Drugs and receptors: an overview of the current state of knowledge. Drugs 40:666-687 (1991).
23. Jenkinson, D., and A. Abbott. Are molecular and electrophysiological data refining models of agonism? Trends Pharmacol. Sci. 11:91-94 (1990).
24. Brown, J. H., and D. Goldstein. Differences in muscarinic receptor reserve for inhibition of adenylate cyclase and stimulation of phosphoinositide hydrolysis in chick heart cells. Mol. Pharmacol. 30:466-470 (1986).
25. Meller, E., K. Bohmaker, Y. Namba, A. J. Friedhoff, and M. Goldstein. Relationship between receptor occupancy and response at striatal dopamine autoreceptors. Mol. Pharmacol. 31:592-598 (1987).
26. Furchgott, R. F. The use of haloalkylamines in the differentiation of receptors and the determination of dissociation constants of receptoragonist complexes. Adv. Drug. Res. 3:21-55 (1966).